We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.15 | 8.80 | 9.50 | 9.15 | 8.91 | 9.15 | 2,482 | 08:00:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.09 | 84.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/3/2019 10:18 | If DE is watching this board would really appreciate his input into whether in general a small bio Tech is best if served by a group of people who all get along well but may be one a bit cosy. Or better in general to have a more dynamic team with different views and perspectives which yes may cause a bit of disruption in a small team but may help overcome a reluctance to make tough decisions to move a business forward. Appreciate he can’t comment directly on share price or if hevus happy nay give him a private call | ivyspivey | |
16/3/2019 10:11 | At the 2017 AGM when around the same time they made all the good announcements of external validation I made the point to RG that this was great but the proof would be in the pudding. They were taken back a bit at the 2018 AGM with yours and other questioning their response to the decline in share price I was hoping that they would take on board the SH concerns and actually address them like top class BOD would. Unfortunately I feel they judge AGMs as just something to bluff their way through and a necessary evil. In such circumstances like yourself will give it a few months but if they have not upped their commercial game then the next opportunity SH should make it absolutely clear how unhappy they are with BOD performance | ivyspivey | |
16/3/2019 10:05 | Yes I admit I let them off lightly but this lack of action or response from BOD since then is simply very unprofessional and unnaceptable and has crossed a line in my mind. ATB | ivyspivey | |
16/3/2019 09:32 | Ivy, no problem, having not previously attended an AGM I was actually very conservative, I definitely won't be next time. | panama7 | |
16/3/2019 09:21 | Morning Panama If you are attending the next EGM( if it is called) or AGM I will look forward to meeting you properly and the opportunity to listen to how the BOD respond to this current mess and to seriously question their performance especially in the light of the plight of many investors here who you have championed here. | ivyspivey | |
16/3/2019 08:54 | With yesterday's closing price we now have a Market Cap way below the value of all the fundraises and there are Investors who believe our BOD have done a fantastic job. If there is not a Biontech deal or a dramatic uplift in the share price in the next three months there will almost definitely have to be an EGM for to raise sufficient funds. I bet our BOD are really looking forward to that scenario. | panama7 | |
15/3/2019 19:30 | yea we Learn so much from you Loz 1/ grass growing techniques (using the sun) 2/ Ploughing from distant observations 3/ 1664 consumption 4/ size of a window 5/ Funding | inanaco | |
15/3/2019 18:36 | Questions that arise from today - Which is the most disturbing/ alarming/ revealing... is it ??? The obvious LOW opinion, as shown today, inane'n'co has of the ability/intelligence of others/EVERYONE.. to 'Think for themselves' - 'Speak to and for themselves' -'Have their own opinions' OR The 'over-inflated' HIGH opinion - HE has of HIMSELF - as shown AGAIN today, of HIS belief in HIS own { Superior ability/intelligence - above ALL others/ EVERYONE } { On ALL matters } . Some / MANY, might/ would opine = Both amount to the same... and lead to FAILURE | the real lozan | |
15/3/2019 18:22 | Wanderer, if that refs to my 20714 No, sadly I can't remember the name at all. It was a very good and accurate set of posts (prophesies) though... ATB | oldnotwise | |
15/3/2019 17:57 | Was it Smithysboy? By any chance | wanderer1210_0 | |
15/3/2019 17:06 | Oh yes, one last thing for open minded readers. The life scientific this week (Ken Gabriel). Interesting section about 22.5 mins in ... worth a listen just to get an idea of where risk can come from if we don't believe. The podcast's available on the BBC Sounds. I'm sure the points he's making are into the future, but so by the looks of things are Scancell's IP value lines. Anyway, as they say, "every little helps" :-) ATB | oldnotwise | |
15/3/2019 17:01 | Panama No, defintely not Lemoore, the poster I'm talking about only ever made one series of posts on LSE over the space of a lunchtime. Once he'd done a demolition job on one particular poster there, he stopped and (literally) minutes later the posts were all gone! It was a complete one off, never saw or heard of him/her again and the username was removed when the posts disappeared. Shame really, but Lemoore I remember well. ATB | oldnotwise | |
15/3/2019 16:55 | ONW, I think you might be talking about Lemoore, at the time he was shouted down by the Happy clappers as are every poster that doesn't agree with them. The fact is there is absolutely no correlation between everything the company have stated over 7 years and where we are today. The company came up with this absurd story at the start that they could sell the Company based on the results from a handful of patients. Once they done that they had a ready market for their shares and have relied on II's and PI's putting in ever more money to justify their original investments. Bar one or two everyone has been played by the BOD of this Company. | panama7 | |
15/3/2019 16:48 | Panama... Errrrm, yeah, tricky one to justify that. I just wish I could remember the date when a guy who got onto LSE one lunchtime (new poster) a few years back, after a particularly frantic morning of posting, when the mantra of the £12 per share and all that was going on. I remember vividly his posting style which was really reasonable, and not in any way shouty, but he pointed out the timelines for reaching validation of share price for Scancell would take many years and various other (at the time ) radical (but subsequently proven) reasons for caution. Interestingly his posts were removed in the early afternoon, but if we were to look through all the back posts (if they were still in history but are not) for "the poster who got it most right" it would be very difficult to top that person's writing. At the time it sounded completely OTT, but my goodness he/she had the timescales right, and the likely path of the share price Shame that wisdom was removed completely in double quick time!!! Anyway, yes, let's hope for the miracle... AIMO ATB | oldnotwise | |
15/3/2019 16:38 | ONW, not looking to good then, for Investors who think the share price doesn't matter I wonder how happy they will be when we have to issue 100's of millions of shares at 4p or below unless the Company come up with a deal that they have had 7 years to consummate. | panama7 | |
15/3/2019 16:29 | Near term chart support 5.63, next down 4.5p... It begins to look like a self fulfilling prophesy again, particularly as the offer slips back to 5.55 after a half hearted attempt on 5.7p earlier after a good bout of (small) buying throughout the day. Still haven't seen any evidence of selling to supply and with no follow through on the upside ... well, only one answer really... AIMO ATB | oldnotwise | |
15/3/2019 16:22 | More Caneston required. | tosh123 | |
15/3/2019 15:57 | yes Tosh but lozan still needs to highlight it ... after all what else can he post on nothing .. | inanaco | |
15/3/2019 15:53 | Berm, a school kid can see the need for funding. | tosh123 | |
15/3/2019 15:44 | Lozan, Yeah, funny thing is that the BOD have been quite open and honest about the need for funding - it's no secret | bermudashorts | |
15/3/2019 15:06 | Lozan, I don't see it as a last resort measure - just standard position for a bio. If baby bios had to wait until they had sufficient funds to complete a trial, none of them would ever get beyond phase I - especially true for oncology trials which can last a couple of years upwards. | bermudashorts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions